344 related articles for article (PubMed ID: 27083116)
1. Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors.
Zhang P; Liu F; Guo F; Zhao Q; Chang J; Guo JT
Antiviral Res; 2016 Jul; 131():40-8. PubMed ID: 27083116
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
[TBL] [Abstract][Full Text] [Related]
3. Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses.
Wei Y; Tavis JE; Ganem D
J Virol; 1996 Sep; 70(9):6455-8. PubMed ID: 8709281
[TBL] [Abstract][Full Text] [Related]
4. Selected mutations of the duck hepatitis B virus P gene RNase H domain affect both RNA packaging and priming of minus-strand DNA synthesis.
Chen Y; Robinson WS; Marion PL
J Virol; 1994 Aug; 68(8):5232-8. PubMed ID: 8035519
[TBL] [Abstract][Full Text] [Related]
5. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.
Campagna MR; Liu F; Mao R; Mills C; Cai D; Guo F; Zhao X; Ye H; Cuconati A; Guo H; Chang J; Xu X; Block TM; Guo JT
J Virol; 2013 Jun; 87(12):6931-42. PubMed ID: 23576513
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Anti-hepatitis B Virus Activity of 2',3'-Dideoxyguanosine.
Zhang P; Zhai S; Chang J; Guo JT
Virol Sin; 2018 Dec; 33(6):538-544. PubMed ID: 30421112
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
[TBL] [Abstract][Full Text] [Related]
8. Amino acids essential for RNase H activity of hepadnaviruses are also required for efficient elongation of minus-strand viral DNA.
Chen Y; Marion PL
J Virol; 1996 Sep; 70(9):6151-6. PubMed ID: 8709240
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
Jo E; Ryu DK; König A; Park S; Cho Y; Park SH; Kim TH; Yoon SK; Ryu WS; Cechetto J; Windisch MP
Antiviral Res; 2020 Mar; 175():104709. PubMed ID: 31940474
[TBL] [Abstract][Full Text] [Related]
10. Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis.
von Weizsäcker F; Köck J; Wieland S; Offensperger WB; Blum HE
Hepatology; 1999 Jul; 30(1):308-15. PubMed ID: 10385672
[TBL] [Abstract][Full Text] [Related]
11. Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes.
Schultz U; Summers J; Staeheli P; Chisari FV
J Virol; 1999 Jul; 73(7):5459-65. PubMed ID: 10364293
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human and duck hepatitis B virus by 2',3'-dideoxy-3'-fluoroguanosine in vitro.
Schröder I; Holmgren B; Oberg M; Löfgren B
Antiviral Res; 1998 Jan; 37(1):57-66. PubMed ID: 9497073
[TBL] [Abstract][Full Text] [Related]
13. Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation.
Yang L; Shi LP; Chen HJ; Tong XK; Wang GF; Zhang YM; Wang WL; Feng CL; He PL; Zhu FH; Hao YH; Wang BJ; Yang DL; Tang W; Nan FJ; Zuo JP
Acta Pharmacol Sin; 2014 Mar; 35(3):410-8. PubMed ID: 24487969
[TBL] [Abstract][Full Text] [Related]
14. cis-Acting sequences that contribute to synthesis of minus-strand DNA are not conserved between hepadnaviruses.
Maguire ML; Loeb DD
J Virol; 2010 Dec; 84(24):12824-31. PubMed ID: 20926578
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation.
Zhao Q; Hu Z; Cheng J; Wu S; Luo Y; Chang J; Hu J; Guo JT
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669831
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA.
Köck J; Nassal M; Deres K; Blum HE; von Weizsäcker F
J Virol; 2004 Dec; 78(24):13812-8. PubMed ID: 15564489
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.
Deres K; Schröder CH; Paessens A; Goldmann S; Hacker HJ; Weber O; Krämer T; Niewöhner U; Pleiss U; Stoltefuss J; Graef E; Koletzki D; Masantschek RN; Reimann A; Jaeger R; Gross R; Beckermann B; Schlemmer KH; Haebich D; Rübsamen-Waigmann H
Science; 2003 Feb; 299(5608):893-6. PubMed ID: 12574631
[TBL] [Abstract][Full Text] [Related]
18. Carbonyl J acid derivatives block protein priming of hepadnaviral P protein and DNA-dependent DNA synthesis activity of hepadnaviral nucleocapsids.
Wang YX; Wen YM; Nassal M
J Virol; 2012 Sep; 86(18):10079-92. PubMed ID: 22787212
[TBL] [Abstract][Full Text] [Related]
19. Cis-preferential recruitment of duck hepatitis B virus core protein to the RNA/polymerase preassembly complex.
von Weizsäcker F; Köck J; Wieland S; Beck J; Nassal M; Blum HE
Hepatology; 2002 Jan; 35(1):209-16. PubMed ID: 11786978
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses.
Seignères B; Pichoud C; Martin P; Furman P; Trépo C; Zoulim F
Hepatology; 2002 Sep; 36(3):710-22. PubMed ID: 12198665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
